Biotech companies have always licensed programs, but never so many from one region in particular.

Clinical trials in China are getting attention at an international oncology gathering in Chicago. China’s surging biotechnology industry is fueling alarm that U.S. dominance in the field is waning.

Biotech is increasingly financed, governed and regulated as though it were a mature pharmaceutical industry rather than a ...

New K-NIBRT training hub addresses South Korea's critical biotech workforce shortage, graduating 3,400+ students in 2025 to ...

This week on "The Readout LOUD," longtime biotech exec Jeremy Levin talks about his new book and the industry's strategic turning point. Listen now.

Panda Biotech recently made its India market debut at the Yarns & Fibers Expo in Mumbai.

Biotech is producing scientific breakthroughs that once seemed impossible. But according to longtime industry executive Jeremy Levin, the institutions ...

As large biopharma companies have increasingly turned to China for novel biotech innovation, political calls in the U.S. to ...

China’s biotech industry is only barely trailing — and in some areas, is already surpassing — America’s. China now initiates ...

The nonprofit is aiming to inspire a new moonshot effort that helps the U.S. maintain its position as a drug innovation ...

From clinical trials to clawback reform, pharma leaders say Greece must move faster to attract investment under Europe’s new ...

By Andrew Silver SHANGHAI, May 26 (Reuters) - China's booming pharmaceutical industry is not being impacted by Beijing's ...